Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-20-008431
Filing Date
2020-07-23
Accepted
2020-07-23 16:38:42
Documents
1
Period of Report
2020-07-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 4217
  Complete submission text file 0001179110-20-008431.txt   5675
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Issuer) CIK: 0000861838 (see all company filings)

EIN.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 111 WAVERLY CIRCLE PHOENIXVILLE PA 19460
Business Address
Tarka Elizabeth Ann (Reporting) CIK: 0001783037 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31918 | Film No.: 201044020